|
ZFAND6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.403280E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.601840E-04 |
| Normal-vs-Stage2 |
1.332820E-01 |
| Normal-vs-Stage3 |
2.570000E-01 |
| Normal-vs-Stage4 |
5.096200E-01 |
| Stage1-vs-Stage2 |
4.590000E-01 |
| Stage1-vs-Stage3 |
1.570020E-01 |
| Stage1-vs-Stage4 |
1.914400E-01 |
| Stage2-vs-Stage3 |
7.020400E-01 |
| Stage2-vs-Stage4 |
5.387800E-01 |
| Stage3-vs-Stage4 |
7.737200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.201850E-03 |
| Normal-vs-AfricanAmerican |
2.496300E-02 |
| Normal-vs-Asian |
9.494400E-01 |
| Caucasian-vs-AfricanAmerican |
5.959000E-01 |
| Caucasian-vs-Asian |
3.330600E-01 |
| AfricanAmerican-vs-Asian |
4.380200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.612600E-04 |
| Normal-vs-Female |
2.162800E-01 |
| Male-vs-Female |
2.155900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.636300E-02 |
| Normal-vs-Extreme_Weight |
9.88760000000255E-05 |
| Normal-vs-Obese |
2.357600E-02 |
| Normal-vs-Extreme_Obese |
2.154300E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.095800E-01 |
| Normal_Weight-vs-Obese |
8.698600E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.098400E-01 |
| Extreme_Weight-vs-Obese |
1.890550E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.921800E-01 |
| Obese-vs-Extreme_Obese |
5.391000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.478600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.389940E-02 |
| Normal-vs-Age(61-80Yrs) |
1.016610E-03 |
| Normal-vs-Age(81-100Yrs) |
2.502300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.637800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.155200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.230600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.615600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.581380E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.458600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.256540E-03 |
| Normal-VS-Type2 PRCC |
2.946000E-02 |
| Normal-VS-KIRP CIMP |
1.887580E-01 |
| Normal-VS-Unclassified PRCC |
3.616000E-02 |
| Type1 PRCC-VS-Type2 PRCC |
7.823200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.424200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.785800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.220800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.370400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.439400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.442400E-04 |
| Normal-vs-N1 |
9.840400E-01 |
| Normal-vs-N2 |
5.520100E-02 |
| N0-vs-N1 |
1.888090E-02 |
| N0-vs-N2 |
8.557600E-01 |
| N1-vs-N2 |
2.732400E-01 |
|
|
